Effects of 3-year denosumab treatment on hip structure in Japanese postmenopausal women and men with osteoporosis

Effects of 3-year denosumab treatment on hip structure in Japanese postmenopausal women and men with osteoporosis

Denosumab, a human monoclonal antibody against RANK ligand, is shown to have strong anti-fracture effects in Japanese osteoporosis patients. However, there have been no data showing actions on Japanese bone architecture. Here we show that denosumab continuously improves several geometrical parameter...

Full description

Bibliographic Details
Main Authors: Teruki Sone, Naohiro Kon, Kenneth W. Gaither, Naoki Okubo, Taisuke Osakabe, Yutaka Nakayama, Masao Fukunaga, Masako Ito, Toshitaka Nakamura
Format: Article
Language:English
Published: Elsevier 2017-12-01
Series:Bone Reports
Subjects:
Osteoporosis
Denosumab
RANK ligand
Hip structural analysis
Japanese
Bone quality
Online Access:http://www.sciencedirect.com/science/article/pii/S2352187217300360

Internet

http://www.sciencedirect.com/science/article/pii/S2352187217300360

Similar Items